Results 181 to 190 of about 3,878,602 (281)

Grand Challenges in Structural Materials

Frontiers in Materials, 2015
John L. Provis
doaj   +1 more source

Evaporate-casting of curvature gradient graphene superstructures for ultra-high strength structural materials. [PDF]

Nat Commun
Lu B, Yu L, Hu Y, Wang Y, Zhao F, Zhao Y, Liu F, Cheng H, Qu L.   +8 more
europepmc   +1 more source

Descriptors for High Throughput in Structural Materials Development. [PDF]

High Throughput, 2019
Steinbacher M, Alexe G, Baune M, Bobrov I, Bösing I, Clausen B, Czotscher T, Epp J, Fischer A, Langstädtler L, Meyer D, Raj Menon S, Riemer O, Sonnenberg H, Thomann A, Toenjes A, Vollertsen F, Wielki N, Ellendt N.   +18 more
europepmc   +1 more source

Structural Materials: Identification of the Constitutive Models and Assessment of the Material Response in Structural Elements Strengthened with Externally-Bonded Composite Material. [PDF]

Materials (Basel), 2020
Zhelyazov T.
europepmc   +1 more source

ALS With and Without Upper Motor Neuron Signs: A Comparative Study Supporting the Gold Coast Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung, E‐nae Cheong, Jungmin So, Heung‐Won Kang, Yangsean Choi, Eun‐Jae Lee, Hyunjin Kim, Young‐Min Lim   +7 more
wiley   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang, Yixiu Pei, Xiaobao Hu, Ying Xiong, Fang Wang, Yanyan Yu, Min Zhu, Dandan Tan, Meihong Zhou, Daojun Hong, Fuqing Zhou   +10 more
wiley   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Parameter Optimization in High-Throughput Testing for Structural Materials. [PDF]

Materials (Basel), 2019
Bader A, Toenjes A, Wielki N, Mändle A, Onken AK, Hehl AV, Meyer D, Brannath W, Tracht K.   +8 more
europepmc   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants.

J Mater Chem B, 2022
Shakil A, Hern FY, Liu C, Temburnikar K, Chambon P, Liptrott N, McDonald TO, Neary M, Owen A, Freel Meyers C, Rannard SP.   +10 more
europepmc   +1 more source